The Financial Times leads on Boris Johnson’s confidence in the
Oxford/Astra Zeneca COVID vaccine despite concerns elsewhere over its
efficacy against new variants.
Kwa tukio lolote la habari, makala au picha wasiliana nasi Diramakini Business Limited saa 24 kupitia +255 719254464 au barua pepe; diramakini@gmail.com
No comments